Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017864HBVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS30076381HIVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS30076382HIVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS30025125HIVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS30025126HIVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS20048520HPVENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS44015542HTLV-1ENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TVIS44050031HTLV-1ENSG00000143393.17protein_codingPI4KBNoNo5298A0A0B4J1S8
Q9UBF8
TCGA Plot Options
Drug Information
GenePI4KB
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009513
UniProt IDQ9UBF8
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830